Double vs Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy
J. Clin. Oncol 2020 Jun 23;[EPub Ahead of Print], F Bridoux, B Arnulf, L Karlin, N Blin, N Rabot, M Macro, V Audard, K Belhadj, B Pegourie, P Gobert, E Cornec Le Gall, B Joly, A Karras, A Jaccard, K Augeul-Meunier, S Manier, B Royer, D Caillot, M Tiab, S Delbes, F Suarez, C Vigneau, S Caillard, N Arakelyan-Laboure, D Roos-Weil, S Chevret, JP FermandFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.